The Board of Directors of Valiant Organics Limited, in their meeting held on May 19, 2026, approved the company’s cessation as a partner of Dhanvallabh Ventures LLP (“DVLLP”) and the disposal of its partnership interest. This transaction, considered a material related party transaction, involves the transfer of 1,86,07,531 equity shares of Valiant Laboratories Limited from DVLLP to Valiant Organics to settle the capital contribution and undistributed profits/losses. Upon the effective date of this cessation, DVLLP will cease to be a subsidiary of the company.

Financial Results Analysis

Valiant Organics Limited reported strong financial results for the quarter ended March 31, 2026 (Q4 FY26). The company achieved a total income of ₹221.79 Crores, compared to ₹160.91 Crores in the previous quarter (Q3 FY26) and ₹204.49 Crores in the corresponding quarter last year (Q4 FY25). The Profit After Tax (PAT) stood at ₹15.72 Crores, showing significant growth compared to ₹3.65 Crores in Q3 FY26 and ₹4.20 Crores in Q4 FY25.

Valiant Organics Limited is a prominent Indian specialty chemicals manufacturer and a key member of the Aarti Group, specializing in intermediate chemicals through complex chemistries like Chlorination, Hydrogenation, and Ammonolysis. In 2025, the company focused on cost optimization and digital transformation, including SAP implementation, to improve operational efficiency and manage debt levels. The company’s shareholding pattern as of March 2026 indicates that promoters hold a 37.89% stake, with public shareholding at 61.88% and a small percentage held by FIIs. Key public shareholders include individuals from the promoter-related families, such as Jaya Chandrakant Gogri and Arti Rajendra Gogri, among others.